Rationale and design of the DIGIT-HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double-blind, placebo-controlled study.

Udo Bavendiek; Dominik Berliner; Lukas Aguirre Dávila; Johannes Schwab; Lars Maier; Sebastian A Philipp; Andreas Rieth; Ralf Westenfeld; Christopher Piorkowski; Kristina Weber; Anja Hänselmann; Maximiliane Oldhafer; Sven Schallhorn; Heiko von der Leyen; Christoph Schröder; Christian Veltmann; Stefan Störk; Michael Böhm; Armin Koch; Johann Bauersachs

doi:10.1002/ejhf.1452

Rationale and design of the DIGIT-HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double-blind, placebo-controlled study.

Udo Bavendiek, Dominik Berliner, Lukas Aguirre Dávila, Johannes Schwab (Co-author), Lars Maier, Sebastian A Philipp, Andreas Rieth, Ralf Westenfeld, Christopher Piorkowski, Kristina Weber, Anja Hänselmann, Maximiliane Oldhafer, Sven Schallhorn, Heiko von der Leyen, Christoph Schröder, Christian Veltmann, Stefan Störk, Michael Böhm, Armin Koch, Johann Bauersachs

Department of Internal Medicine VIII, Division of Cardiology

Research output: Contribution to journal › Original Article › peer-review

59 Citations (Web of Science)

Original language	English
Pages (from-to)	676-684
Journal	EUROPEAN JOURNAL OF HEART FAILURE
Volume	21
Issue number	5
DOIs	https://doi.org/10.1002/ejhf.1452
Publication status	Published - 2019

Keywords

2016 ESC GUIDELINES
DIGOXIN
MORTALITY
HOSPITALIZATION
ASSOCIATION
ENALAPRIL
SURVIVAL
WITHDRAWAL
REDUCTION
INSIGHTS

Access to Document

10.1002/ejhf.1452

Cite this

Bavendiek, U., Berliner, D., Dávila, L. A., Schwab, J., Maier, L., Philipp, S. A., Rieth, A., Westenfeld, R., Piorkowski, C., Weber, K., Hänselmann, A., Oldhafer, M., Schallhorn, S., von der Leyen, H., Schröder, C., Veltmann, C., Störk, S., Böhm, M., Koch, A., & Bauersachs, J. (2019). Rationale and design of the DIGIT-HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double-blind, placebo-controlled study. EUROPEAN JOURNAL OF HEART FAILURE , 21(5), 676-684. https://doi.org/10.1002/ejhf.1452

Bavendiek, Udo ; Berliner, Dominik ; Dávila, Lukas Aguirre et al. / Rationale and design of the DIGIT-HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double-blind, placebo-controlled study. In: EUROPEAN JOURNAL OF HEART FAILURE 2019 ; Vol. 21, No. 5. pp. 676-684.

@article{3045bab29a924ef79cd83634d245f26c,

title = "Rationale and design of the DIGIT-HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double-blind, placebo-controlled study.",

keywords = "2016 ESC GUIDELINES, DIGOXIN, MORTALITY, HOSPITALIZATION, ASSOCIATION, ENALAPRIL, SURVIVAL, WITHDRAWAL, REDUCTION, INSIGHTS",

author = "Udo Bavendiek and Dominik Berliner and D{\'a}vila, {Lukas Aguirre} and Johannes Schwab and Lars Maier and Philipp, {Sebastian A} and Andreas Rieth and Ralf Westenfeld and Christopher Piorkowski and Kristina Weber and Anja H{\"a}nselmann and Maximiliane Oldhafer and Sven Schallhorn and {von der Leyen}, Heiko and Christoph Schr{\"o}der and Christian Veltmann and Stefan St{\"o}rk and Michael B{\"o}hm and Armin Koch and Johann Bauersachs",

note = "Schwab, J: Department of Cardiology, Cardiovascular Center, Clinical Center Nuernberg, Paracelsus Medical University, Nuernberg, Germany.",

year = "2019",

doi = "10.1002/ejhf.1452",

language = "English",

volume = "21",

pages = "676--684",

journal = "EUROPEAN JOURNAL OF HEART FAILURE ",

issn = "1388-9842",

publisher = "Wiley Verlag ",

number = "5",

}

Bavendiek, U, Berliner, D, Dávila, LA, Schwab, J, Maier, L, Philipp, SA, Rieth, A, Westenfeld, R, Piorkowski, C, Weber, K, Hänselmann, A, Oldhafer, M, Schallhorn, S, von der Leyen, H, Schröder, C, Veltmann, C, Störk, S, Böhm, M, Koch, A & Bauersachs, J 2019, 'Rationale and design of the DIGIT-HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double-blind, placebo-controlled study.', EUROPEAN JOURNAL OF HEART FAILURE , vol. 21, no. 5, pp. 676-684. https://doi.org/10.1002/ejhf.1452

Rationale and design of the DIGIT-HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double-blind, placebo-controlled study. / Bavendiek, Udo; Berliner, Dominik; Dávila, Lukas Aguirre et al.
In: EUROPEAN JOURNAL OF HEART FAILURE , Vol. 21, No. 5, 2019, p. 676-684.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Rationale and design of the DIGIT-HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double-blind, placebo-controlled study.

AU - Bavendiek, Udo

AU - Berliner, Dominik

AU - Dávila, Lukas Aguirre

AU - Schwab, Johannes

AU - Maier, Lars

AU - Philipp, Sebastian A

AU - Rieth, Andreas

AU - Westenfeld, Ralf

AU - Piorkowski, Christopher

AU - Weber, Kristina

AU - Hänselmann, Anja

AU - Oldhafer, Maximiliane

AU - Schallhorn, Sven

AU - von der Leyen, Heiko

AU - Schröder, Christoph

AU - Veltmann, Christian

AU - Störk, Stefan

AU - Böhm, Michael

AU - Koch, Armin

AU - Bauersachs, Johann

N1 - Schwab, J: Department of Cardiology, Cardiovascular Center, Clinical Center Nuernberg, Paracelsus Medical University, Nuernberg, Germany.

PY - 2019

Y1 - 2019

KW - 2016 ESC GUIDELINES

KW - DIGOXIN

KW - MORTALITY

KW - HOSPITALIZATION

KW - ASSOCIATION

KW - ENALAPRIL

KW - SURVIVAL

KW - WITHDRAWAL

KW - REDUCTION

KW - INSIGHTS

U2 - 10.1002/ejhf.1452

DO - 10.1002/ejhf.1452

M3 - Original Article

C2 - 30892806

SN - 1388-9842

VL - 21

SP - 676

EP - 684

JO - EUROPEAN JOURNAL OF HEART FAILURE

JF - EUROPEAN JOURNAL OF HEART FAILURE

IS - 5

ER -

Bavendiek U, Berliner D, Dávila LA, Schwab J, Maier L, Philipp SA et al. Rationale and design of the DIGIT-HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double-blind, placebo-controlled study. EUROPEAN JOURNAL OF HEART FAILURE . 2019;21(5):676-684. doi: 10.1002/ejhf.1452